-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Uk8Sy4inDRWPgPGGQ02rIuxXn1YoI6kdLyT+8IeaaGmA6Fb0xCoj+9rjuIcB2gtM vhNP4QSenxIZDBAvxdhEbA== 0001012975-10-000039.txt : 20100218 0001012975-10-000039.hdr.sgml : 20100218 20100218190133 ACCESSION NUMBER: 0001012975-10-000039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100216 FILED AS OF DATE: 20100218 DATE AS OF CHANGE: 20100218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stampacchia Otello CENTRAL INDEX KEY: 0001361712 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50440 FILM NUMBER: 10617738 MAIL ADDRESS: STREET 1: 12 RUE DE LA COULOUVRENIERE CITY: 1204 GENEVA STATE: V8 ZIP: 1204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MICROMET, INC. CENTRAL INDEX KEY: 0001131907 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 522243564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6707 DEMOCRACY BOULEVARD STREET 2: SUITE 505 CITY: BETHESDA STATE: MD ZIP: 20817 BUSINESS PHONE: 240-752-1420 MAIL ADDRESS: STREET 1: 6707 DEMOCRACY BOULEVARD STREET 2: SUITE 505 CITY: BETHESDA STATE: MD ZIP: 20817 FORMER COMPANY: FORMER CONFORMED NAME: CANCERVAX CORP DATE OF NAME CHANGE: 20010108 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-02-16 0001131907 MICROMET, INC. MITI 0001361712 Stampacchia Otello C/O OMEGA FUND MANAGEMENT UK LLP 32 OLD BURLINGTON STREET LONDON X0 W1S 3AT UNITED KINGDOM 1 0 0 0 Common Stock 2010-02-16 4 S 0 8000 8.0457 D 2450413 I By Fund Common Stock 2010-02-17 4 S 0 11000 8.00 D 2439413 I By Fund Common Stock 2010-02-18 4 S 0 25000 8.0262 D 2414413 I By Fund The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2009. Consists of 5,327 shares sold by Omega Fund I, L.P. ("Omega I") and 2,673 shares sold by Omega Fund III, L.P. ("Omega III"). Consists of 7,324 shares sold by Omega I and 3,676 shares sold by Omega III. Consists of 16,647 shares sold by Omega I and 8,353 shares sold by Omega III. Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $8 to $8.10 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $8.00 to $8.00 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $8.00 to $8.08 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Consists of 1,631,631 shares beneficially owned by Omega I and 818,782 shares beneficially owned by Omega III. Consists of 1,624,307 shares beneficially owned by Omega I and 815,106 shares beneficially owned by Omega III. Consists of 1,607,660 shares beneficially owned by Omega I and 806,753 shares beneficially owned by Omega III. Consists of securities held directly by Omega III. Omega Fund III GP, L.P. ("Omega III GPLP") is the general partner of Omega III. Omega Fund III G.P., Ltd. ("Omega III GPLtd") is the general partner of Omega III GPLP. Omega Fund Management Limited ("Omega Management") is the sole shareholder of Omega III GPLtd. Sigma Holding Limited ("Sigma") is the sole shareholder of Omega Management. Otello Stampacchia ("Stampacchia") is the sole shareholder of Sigma and is also a director of Micromet, Inc. Stampacchia disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Consists of securities held directly by Omega I. Omega Fund GP, Ltd. ("Omega GP") is the general partner of Omega I. Omega Management is the sole shareholder of Omega GP. Sigma is the sole shareholder of Omega Management. Stampacchia is the sole shareholder of Sigma and is also a director of Micromet, Inc. Stampacchia disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. /s/ Anne-Mari Paster, as Attorney-in-Fact for Otello Stampacchia 2010-02-18 -----END PRIVACY-ENHANCED MESSAGE-----